Although that care bill 841 on medicines From its discussion to its adoption in the first debate, more than a year passed, there was still a lot of “stuff to cut”, which delayed its discussion at the plenary session of the National Assembly.

which took two weeks to read.

He announced Panama America that this week there will most likely be a deadlock that will cause the discussion of the project to be suspended until a consensus is reached with the government made up of the Ministry of Health (Minsa) and the Social Security Fund (CSS).

Between Thursday and next week there are agreements that enable quick approval of the project.

“To refine it and reduce the days of discussion and we can discuss it in three days of long sessions

According to Daniel Ramos, a consensus was reached in regulatory part of reformswhich has to do with health records, providers and conflicts of interest, among various topics.

However, a consensus is still sought on issues related to the procurement and marketing processes of medicinesit is considered ‘essential’ to solving the problem at hand.

Eye, Enma Pinzón, patient representative He said that it was obvious that they endured that project.

“And we understood from the first day, when the president of the Commission for Labor and Health exposed and He hinted that he might be dropped for the first hearing“, he commented.

A patient spokesperson admits that there are conflicting points in the proposal, such as the fact that a unique list of medicines at the national levela problem that, for example, CSS objects to.

However, the position he will take as an interested party in this matter is related to financing of the drug procurement system which is imperative to eradicate shortages.

“As long as there is no healthy budget, we will never have a complete supply, because medicines must be bought with moneyPinzon said.

In the project, new article, 178Bsuggests that the savings generated on the budget items for the procurement of medicines, medical materials and other products for human health are not used to finance other expenditure items.

This is the intention of Minsa, which patients welcome this topic is developed in a new chapter to ensure that medicines are robust.